Status:
COMPLETED
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
Lead Sponsor:
Genentech, Inc.
Conditions:
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose c...
Eligibility Criteria
Inclusion
- Signed Informed Consent and Authorization document
- Metastatic, or locally advanced and unresectable, adenocarcinoma of the colon or rectum
- Receiving Avastin as a component of first-line chemotherapy
- First-line chemotherapy plus Avastin initiated \<=4 months prior to enrollment in the study
Exclusion
- Patients who have contraindications for treatment with Avastin (see the Avastin Package Insert) or who would incur excessive risks with Avastin treatment are ineligible for this study.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
1953 Patients enrolled
Trial Details
Trial ID
NCT00097578
Start Date
March 1 2004
End Date
July 1 2008
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genentech Central Contact
South San Francisco, California, United States, 94080